Lin Guey, PhD

Lin Guey, PhD, is Chief Scientific Officer of Therapeutics Research at Moderna, where she leads research advancing mRNA medicines across oncology, rare diseases, autoimmunity, and new frontiers. She brings extensive drug development experience spanning research, nonclinical and clinical development, and program leadership. Previously, she held senior leadership roles at Shire and Pfizer. Lin holds a PhD in Statistics and BS in Mathematics from Stony Brook University, and completed her postdoctoral training in molecular and genetic epidemiology at the Spanish National Cancer Research Center.